Stage III Prostate Adenocarcinoma AJCC v7

specific

Stage II includes: IIA (T1a-c, N0, M0, PSA less than 20, Gleason 7); (T1a-c, N0, M0, PSA equal or more than 10 and less than 20, Gleason equal or less than 6); (T2a, N0, M0, PSA less than 20, Gleason equal or less than 7); (T2b, N0, M0, PSA less than 20, Gleason equal or less than 7); (T2b, N0, M0, PSA X, Gleason X); IIB (T2c, N0, M0, Any PSA, Any Gleason); (T1-2, N0, M0, PSA equal or more than 20, Any Gleason); (T1-2, N0, M0, Any PSA, Gleason equal or more than 8). T1a: Tumor incidental histol

61

Centers

47

Active Trials

Cancer Funding

Top Centers for Stage III Prostate Adenocarcinoma AJCC v7(61)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
73.0
2
NCI Comprehensive
Active Research Program
56.0
3
NCI Comprehensive
Active Research Program
56.0
4
NCI Comprehensive
Active Research Program
56.0
5
NCI Comprehensive
Active Research Program
56.0
6
NCI Comprehensive
Active Research Program
56.0
7
NCI Comprehensive
Active Research Program
56.0
8
NCI Comprehensive
Active Research Program
56.0
9
NCI Comprehensive
Active Research Program
56.0
10
NCI Comprehensive
Active Research Program
56.0
11
NCI Comprehensive
Active Research Program
56.0
12
NCI Comprehensive
Active Research Program
56.0
13
NCI Comprehensive
Active Research Program
56.0
1456.0
15
NCI Comprehensive
Active Research Program
56.0
16
NCI Comprehensive
Active Research Program
56.0
17
NCI Comprehensive
Active Research Program
56.0
18
NCI Comprehensive
Active Research Program
56.0
19
NCI Comprehensive
Active Research Program
56.0
20
NCI Comprehensive
Active Research Program
56.0
21
NCI Clinical
Active Research Program
56.0
22
NCI Comprehensive
Active Research Program
56.0
23
Active Research Program
56.0
24
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
56.0
25
NCI Clinical
Active Research Program
56.0
26
Active Research Program
56.0
27
NCI Clinical
Active Research Program
56.0
28
NCI Comprehensive
Active Research Program
56.0
29
NCI Comprehensive
Active Research Program
56.0
30
NCI Comprehensive
Active Research Program
56.0
31
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
56.0
32
Active Research Program
56.0
33
NCI Comprehensive
Active Research Program
56.0
34
Active Research Program
56.0
35
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
56.0
36
Active Research Program
56.0
37
Active Research Program
56.0
38
Active Research Program
56.0
39
Active Research Program
56.0
40
Active Research Program
56.0
41
Active Research Program
56.0
42
Active Research Program
56.0
43
Active Research Program
56.0
44
Active Research Program
56.0
45
Active Research Program
56.0
46
Active Research Program
56.0
47
NCI Comprehensive
33.9
48
NCI Comprehensive
33.9
49
NCI Comprehensive
33.9
50
NCI Comprehensive
33.9
5133.9
52
NCI Comprehensive
33.9
53
NCI Comprehensive
33.9
5433.9
5533.9
5633.9
5733.9
58
NCI Comprehensive
33.9
5933.9
6033.9
6133.9

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →